Materials & Resources » Mining, Metals & Minerals | Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc. | Balance Sheet

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
72.80
98.80
25.20
19.10
3,367.70
1,393.60
Other Current Assets
-
14.00
0.30
3.00
149.70
227.20
Total Current Assets
72.80
112.80
25.50
22.10
3,517.40
1,620.90
Net Property, Plant & Equipment
-
1.50
3.20
1.60
120.40
974.30
Intangible Assets
-
4,409.90
-
-
-
-
Total Assets
72.80
4,524.10
28.70
23.70
3,637.80
3,184.90
ST Debt & Current Portion LT Debt
130.80
48.80
-
-
-
Accounts Payable
47.40
-
-
-
386.90
Other Current Liabilities
-
25.30
338.30
491.20
312.30
Total Current Liabilities
178.10
74.10
338.30
491.20
699.10
Total Liabilities
178.10
74.10
338.30
491.20
699.10
Common Equity (Total)
105.40
4,450.00
309.60
467.40
2,938.60
Total Shareholders' Equity
105.40
4,450.00
309.60
467.40
2,938.60
Total Equity
105.40
4,450.00
309.60
467.40
2,938.60
Liabilities & Shareholders' Equity
72.80
4,524.10
28.70
23.70
3,637.80

About Cannabics Pharmaceuticals

View Profile
Address
No. 3 Bethesda Metro Center
Bethesda Maryland 20814
United States
Employees -
Website http://www.cannabics.com
Updated 07/08/2019
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.